Humanwell Healthcare Group Co

Humanwell Healthcare Group Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Humanwell Healthcare Group Co (600079.SS) as of Nov 8, 2026 is 12.27. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 14.28 — a change of -14.07% (lower).

P/CF

12.27

YoY

-14.07%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Humanwell Healthcare Group Co is 2025 12.27 . P/CF (Price-to-Cash-Flow Ratio) of Humanwell Healthcare Group Co was 2024 14.28 . It decreases by -14.07% lower compared to the previous year.

The Humanwell Healthcare Group Co P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
51.26 CNY
Jan 1, 2019
15.17 CNY
Jan 1, 2020
15.54 CNY
Jan 1, 2021
14.19 CNY
Jan 1, 2022
12.66 CNY
Jan 1, 2023
15.71 CNY
Jan 1, 2024
14.28 CNY
Jan 1, 2025
12.27 CNY
The Humanwell Healthcare Group Co P/CF history
YEARP/CFYoY
12.27-14.07%
14.28-9.10%
15.71+24.09%
12.66-10.74%
14.19-8.73%
15.54+2.48%
15.17-70.41%
51.26-93.67%
809.86+1,279.39%
58.71-40.89%
99.32+61.53%
61.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

P/CF (Price-to-Cash-Flow Ratio) of Humanwell Healthcare Group Co is 12.27 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Humanwell Healthcare Group Co changed from 14.28 to 12.27, representing a -14.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Humanwell Healthcare Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Humanwell Healthcare Group Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Humanwell Healthcare Group Co